Skip to main content

Table 3 Association of EAT thickness with adverse outcomes in the GDM group (n = 314)

From: Epicardial adipose tissue thickness as a potential predictor of gestational diabetes mellitus: a prospective cohort study

 

Cases with adverse outcomes

With adverse outcomes

Without adverse outcomes

P*

OR (95%CI)

P#

Total

91 (29%)

7.29 ± 0.66

6.27 ± 0.64

< 0.001

8.28 (5.10–13.43)

< 0.001

Large size for gestational age

54 (17%)

7.19 ± 0.80

6.43 ± 0.73

< 0.001

3.47 (2.29–5.26)

< 0.001

Neonatal hypoglycemia

23 (7%)

7.25 ± 0.73

6.51 ± 0.77

< 0.001

3.10 (1.78–5.37)

< 0.001

Admission to NICU

54 (17%)

7.28 ± 0.65

6.41 ± 0.74

< 0.001

4.38 (2.81–6.84)

< 0.001

Preterm delivery

41 (13%)

7.36 ± 0.53

6.44 ± 0.76

< 0.001

4.67 (2.84–7.68)

< 0.001

Hyperbilirubinemia

23 (7%)

7.39 ± 0.64

6.50 ± 0.77

< 0.001

4.04 (2.24–7.28)

< 0.001

  1. CI Confidence interval, EAT Epicardial adipose tissue, GDM Gestational diabetes mellitus, NICU Neonatal intensive care unit, OR odds ratio
  2. P*: P-value of independent-samples t-test
  3. P#: P-value of univariate regression between epicardial adipose tissue thickness and adverse outcomes using generalized linear models